Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate [Phase 4]
Phase 4 trial evaluating the effect of silymarin in rheumatoid arthritis patients treated with methotrexate; not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Manual Diaphragmatic Release on Ventilatory Functions in Women With Rheumatoid Arthritis [NA]
A clinical trial is evaluating the effect of manual diaphragmatic release on ventilatory function in women with rheumatoid arthritis. The st…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Rheumatology Diet Study
A rheumatology dietary intervention study sponsored by the University of Central Florida is currently recruiting, listing multiple autoimmun…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: NexGen TM Tibia Clinical Outcomes Study [NA]
Results from the NexGen tibia clinical outcomes study have been posted after completion, evaluating outcomes across osteoarthritis and relat…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Impact of Bone Mineral Density on Fracture Risk Assessment in RA
This completed clinical trial evaluated how bone mineral density measurements influence fracture risk assessment in patients with rheumatoid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)
Completed real-world evidence study in rheumatoid arthritis (POWER) evaluating patient outcomes; no specific drug results are disclosed in t…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Impact of Vitamin D in Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial update evaluating the impact of Vitamin D (cholecalciferol) in rheumatoid arthritis. The study has completed.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
A Czech Republic clinical study on the epidemiology, management, and comorbidity patterns of alopecia areata has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component [NA]
Completed clinical trial evaluating the Metasul Monoblock Component Cup in a hip resurfacing procedure with the Durom hip resurfacing femora…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
An observational, multi-center study in rheumatoid arthritis patients with inadequate response or intolerance to conventional DMARDs who are…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: EMDR for Persistent Pain in RA [NA]
A clinical trial to evaluate EMDR therapy for persistent pain in rheumatoid arthritis is currently enrolling by invitation. The sponsor is M…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Advanced Therapeutics in Rheumatoid Arthritis (RA) [Phase 4]
Phase 4 clinical trial update for Advanced Therapeutics in Rheumatoid Arthritis; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Evolution and Treatments of Chronic Inflammatory Systemic Diseases
A recruiting study (NCT04191395) exploring evolution and treatment of chronic inflammatory systemic diseases, including inflammatory bowel d…
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Rheum@Home: RA Remote Patient Monitoring [NA]
A clinical trial for rheumatoid arthritis remote patient monitoring called Rheum@Home was withdrawn.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
A clinical trial from University Hospital Tours is evaluating thoracic ultrasound as a tool to detect rheumatoid arthritis-associated inters…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis [NA]
An ongoing clinical trial evaluating biodistribution, dosimetry, and imaging performance of Ga-68 labeled DOTA-Siglec-9 in healthy subjects …
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) [Phase 2]
Phase 2 study of Rosnilimab in moderate-to-severe rheumatoid arthritis is currently active but not recruiting.
-
FDA approval · 2024-11-22FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Naproxen and Esomeprazole Magnesium (ANDA 213699), establishing a generic…
-
FDA approval · 2024-11-22FDA Approved: RELAFEN DS — Supplemental Application (Carwin Pharmaceutical Associates, LLC)
The FDA approved a supplemental application for Relafen DS (nabumetone) submitted by Carwin Pharmaceutical Associates, LLC.
-
FDA approval · 2024-11-22FDA Approved: ETODOLAC — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for etodolac filed by Ipca Laboratories Limited. This represents regulatory clearance for this g…
-
FDA approval · 2024-11-21FDA Approved: NABUMETONE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Nabumetone from Exelan Pharmaceuticals Inc., effectively updating its labeling under an existing…
-
FDA approval · 2024-11-21FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA supplemental approval for tolmetin sodium under Atland Pharmaceuticals, LLC; the submission indicates a supplemental application proceed…
-
FDA label_change · 2024-11-21FDA Approved: ETODOLAC — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Etodolac from ANI Pharmaceuticals, updating the labeling for this generic product.
-
FDA approval · 2024-11-21FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc., updating the product's la…
-
FDA approval · 2024-11-21FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for Tolmetin Sodium (generic tolmetin) from Atland Pharmaceuticals, LLC.